KR920704117A - 피브리노겐 직접 분석 방법 - Google Patents

피브리노겐 직접 분석 방법

Info

Publication number
KR920704117A
KR920704117A KR1019920701275A KR920701275A KR920704117A KR 920704117 A KR920704117 A KR 920704117A KR 1019920701275 A KR1019920701275 A KR 1019920701275A KR 920701275 A KR920701275 A KR 920701275A KR 920704117 A KR920704117 A KR 920704117A
Authority
KR
South Korea
Prior art keywords
plasma
sample
concentration
fibrinogen
measuring
Prior art date
Application number
KR1019920701275A
Other languages
English (en)
Korean (ko)
Inventor
줄리에 프란세스 호프만
자네트 블랙 칼라한
찰스 헤르마스 스워프
Original Assignee
에프.지.엠.헤르만스 에이.지.제이.베르미렌
악조 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프.지.엠.헤르만스 에이.지.제이.베르미렌, 악조 엔. 브이. filed Critical 에프.지.엠.헤르만스 에이.지.제이.베르미렌
Publication of KR920704117A publication Critical patent/KR920704117A/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1019920701275A 1989-12-01 1990-11-30 피브리노겐 직접 분석 방법 KR920704117A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44394889A 1989-12-01 1989-12-01
US443,948 1989-12-01
PCT/US1990/006988 WO1991008460A1 (en) 1989-12-01 1990-11-30 Direct fibrinogen assay

Publications (1)

Publication Number Publication Date
KR920704117A true KR920704117A (ko) 1992-12-19

Family

ID=23762843

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701275A KR920704117A (ko) 1989-12-01 1990-11-30 피브리노겐 직접 분석 방법

Country Status (9)

Country Link
EP (1) EP0502103A4 (xx)
JP (1) JPH05503008A (xx)
KR (1) KR920704117A (xx)
AU (1) AU641459B2 (xx)
CA (1) CA2068221A1 (xx)
FI (1) FI922312A0 (xx)
IE (1) IE904244A1 (xx)
WO (1) WO1991008460A1 (xx)
ZA (1) ZA909564B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
JP4486260B2 (ja) 1999-02-04 2010-06-23 バイオメリュー・インコーポレイテッド 患者サンプルにおける止血機能不全の存在を予測するための方法および装置
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
CN110257475B (zh) * 2019-06-28 2023-05-02 深圳市国赛生物技术有限公司 纤维蛋白原检测试剂及其制备方法及检测试剂制品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432268A (en) * 1964-08-28 1969-03-11 Peter Unger Method and apparatus for testing cell suspensions
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US3833864A (en) * 1972-11-30 1974-09-03 R Kiess Digital direct reading colorimeter
US3861877A (en) * 1974-01-21 1975-01-21 Clinical Technology Inc Optical analysis of fluids
US3905769A (en) * 1974-02-28 1975-09-16 Bagley Wallace E Method and apparatus for measuring prothrombin time and the like
US3989382A (en) * 1975-01-22 1976-11-02 Bio-Data Corporation Platelet aggregation monitoring device
EP0059277A1 (en) * 1981-03-02 1982-09-08 J. & P. Coats, Limited Rapid quantative measurement of fibrinogen in blood plasma
AT382971B (de) * 1981-06-16 1987-05-11 Hoffmann La Roche Verfahren und vorrichtung zur messung der blutgerinnungszeit
GB8426004D0 (en) * 1984-10-15 1984-11-21 Ortho Diagnostic Systems Inc Coagulation monitoring
IT1209604B (it) * 1984-11-27 1989-08-30 Instrumentation Lab Spa Metodo ed apparecchiatura per la misura di parametri di coagulazione.

Also Published As

Publication number Publication date
AU6898391A (en) 1991-06-26
AU641459B2 (en) 1993-09-23
EP0502103A4 (en) 1993-05-05
ZA909564B (en) 1992-11-25
IE904244A1 (en) 1991-06-05
EP0502103A1 (en) 1992-09-09
FI922312A (fi) 1992-05-21
WO1991008460A1 (en) 1991-06-13
CA2068221A1 (en) 1991-06-02
FI922312A0 (fi) 1992-05-21
JPH05503008A (ja) 1993-05-27

Similar Documents

Publication Publication Date Title
FI922478A0 (fi) Foerfarande foer observering av inmatning av reagens vid scanningspektrofotometri.
DK155052C (da) Reagens, testmateriale og fremgangsmaade til detektering af naervaerelsen og/eller bestemmelse af koncentrationen af glucose i en forsoegsproeve
DK0659275T3 (da) Analytisk testapparat med indbygget negativ og positiv kontrol
DE69407975T2 (de) Reagenzsystem zur eichung von pipetten und anderen volumetrischen messgeräten
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
KR920704117A (ko) 피브리노겐 직접 분석 방법
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
NO903748L (no) Fremgangsmaate ved enzymatisk bestemmelse av analyttkonsentrasjoner.
Yamada et al. A new APTT assay employing a chromogenic substrate and a centrifugal autoanalyzer
BR9906995A (pt) Cubeta de reação, aparelho automático de dosagem imunológica, e, processo automático de dosagem imunológica
CZ146198A3 (cs) Reagenční směs pro stanovení hemoglobinu, obsahující kyanid a metoda, zajišťující přijatelnou přesnost měření, přesnost výsledků a eliminaci interference bílých krvinek na automatických hematologických analyzátorech
DK59589D0 (da) Analysemetoder og praeparater og udstyr til anvendelse derved
SE8304989D0 (sv) Anordning for metning av gasandelen syre, kolmonoxid och koldioxid i gasformiga eller flytande prover, i synnerhet i andedrekten och i blodet
SU1622804A1 (ru) Способ количественного рентгенофлуоресцентного анализа
DE68916714D1 (de) Verfahren zur Bestimmung von Endotoxinen.
IL127276A0 (en) Process to eliminate hemoglobin errors during the determination of albumin
SU1075130A1 (ru) Способ измерени концентрации
Kamata et al. Rayleigh ratio for benzene and its temperature dependence.
Wilkins Jr et al. Measurement of bisulfite in biologic solutions
SU1465761A1 (ru) Способ определени воды в диоксане
SU1492253A1 (ru) Способ определени кислорода в углеводородных жидкост х и газовых смес х
KR830004827A (ko) 혈장 내 피브리노오겐의 양을 신속하게 측정하는 방법
JPH01213555A (ja) カール・フィシャー試薬を用いる水分測定法
SU1829614A1 (ru) Способ определения совместимости охлаждающих жидкостей
HU185209B (en) Cuvette system for calorimeters, photmeters and similars

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee